Revolution Medicines · 13 hours ago
Executive Director/Vice President, Healthcare Law
Redwood City, CA
Full-time
Hybrid
Director/Executive
$311K/yr - $383K/yr
15+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Executive Director or Vice President of Healthcare Law will provide strategic legal guidance for commercialization activities, ensuring compliance with healthcare regulations and advising on market access and patient support programs.
Health CareLife ScienceMedical
Responsibilities
Serve as a legal advisor to members of the executive team on a wide range of commercialization issues with broad enterprise impact
Serve as legal representative for Commercialization and Medical-related committees and teams, including promotional review, medical materials, and educational and charitable grants
Serve as the lead counsel for healthcare regulatory law, including the FDCA and related Regulations, and Guidance Documents, fraud and abuse laws and guidance (Anti-Kickback Statute, False Claims Act, OIG Guidance and Advisory Opinions), and federal and state transparency and reporting laws
Provide legal counsel on regulatory interactions with FDA and other regulatory authorities
Coordinate with Compliance sub-function to operationalize compliance in commercialization activities, including related to promotional materials, scientific exchange, and interactions with HCPs
Provide strategic legal advice related to patient support programs, patient hubs, market access, pricing, reimbursement, and distribution via different channels and interest groups (e.g., specialty distributors, specialty pharmacies, PBMs, GPOs, 340B hospitals)and oversee commercial contracting
Advise on issues regarding clinical trials, including related to CT.gov compliance, data privacy, interactions with clinical sites and investigators, CTA contracting and ICFs
Proactively monitor emerging healthcare and regulatory law trends, such as Biosecure, IRA, and MFN pricing, and assess and communicate their impact on RevMed
Build and manage teams in a dynamic high-growth environment
Qualification
Required
JD degree with 15+ years of legal experience, including leadership experience at a commercial stage biotech or pharmaceutical company
Deep familiarity with FDA advertising and promotion compliance
Strong contracting acumen with ability to advise clinical, medical, and commercial teams
Exceptional executive communication, stakeholder management, and negotiation skills; ability to convey complex legal risks in clear, business‑centric terms
Demonstrated experience shaping legal strategy across multiple substantive areas
Experience supporting product launches
Experience hiring and developing legal teams
Collaborative, flexible, positive and pragmatic work style with excellent written and verbal communication skills
Excellent interpersonal and collaborative skills that inspire trust and alignment across functions
Ability to maintain confidentiality and operate with high ethical standards and professionalism
Ability to thrive in a collaborative team setting and a desire to be innovative in rapidly evolving and fast-paced corporate environment
Champions RevMed's values (Tireless Commitment to Patients, Transformative Science, Exceptional Together, Total Integrity, Inclusiveness and Fairness)
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Genetic Engineering News
2026-02-02
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase